Theragen Etex Co.,Ltd. Statistics

Total Valuation

Theragen Etex Co.,Ltd. has a market cap or net worth of KRW 98.90 billion. The enterprise value is 140.51 billion.

Market Cap	98.90B
Enterprise Value	140.51B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Theragen Etex Co.,Ltd. has 32.01 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	32.01M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.25%
Owned by Institutions (%)	1.02%
Float	26.54M

Valuation Ratios

The trailing PE ratio is 3.68.

PE Ratio	3.68
Forward PE	n/a
PS Ratio	0.40
PB Ratio	0.60
P/TBV Ratio	0.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.76, with an EV/FCF ratio of -36.68.

EV / Earnings	5.09
EV / Sales	0.56
EV / EBITDA	6.76
EV / EBIT	9.48
EV / FCF	-36.68

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.28.

Current Ratio	1.27
Quick Ratio	0.90
Debt / Equity	0.28
Debt / EBITDA	2.79
Debt / FCF	-13.26
Interest Coverage	4.61

Financial Efficiency

Return on equity (ROE) is 17.99% and return on invested capital (ROIC) is 3.86%.

Return on Equity (ROE)	17.99%
Return on Assets (ROA)	2.92%
Return on Capital (ROIC)	3.86%
Revenue Per Employee	1.24B
Profits Per Employee	136.63M
Employee Count	202
Asset Turnover	0.95
Inventory Turnover	4.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-26.78%
50-Day Moving Average	3,341.40
200-Day Moving Average	3,746.33
Relative Strength Index (RSI)	39.41
Average Volume (20 Days)	102,690

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theragen Etex Co.,Ltd. had revenue of KRW 250.00 billion and earned 27.60 billion in profits. Earnings per share was 862.30.

Revenue	250.00B
Gross Profit	123.46B
Operating Income	12.28B
Pretax Income	31.30B
Net Income	27.60B
EBITDA	18.23B
EBIT	12.28B
Earnings Per Share (EPS)	862.30

Full Income Statement

Balance Sheet

The company has 28.17 billion in cash and 50.80 billion in debt, giving a net cash position of -22.63 billion or -707.15 per share.

Cash & Cash Equivalents	28.17B
Total Debt	50.80B
Net Cash	-22.63B
Net Cash Per Share	-707.15
Equity (Book Value)	184.69B
Book Value Per Share	5,177.48
Working Capital	26.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.50 billion and capital expenditures -13.33 billion, giving a free cash flow of -3.83 billion.

Operating Cash Flow	9.50B
Capital Expenditures	-13.33B
Free Cash Flow	-3.83B
FCF Per Share	-119.70

Full Cash Flow Statement

Margins

Gross margin is 49.38%, with operating and profit margins of 4.91% and 11.04%.

Gross Margin	49.38%
Operating Margin	4.91%
Pretax Margin	12.52%
Profit Margin	11.04%
EBITDA Margin	7.29%
EBIT Margin	4.91%
FCF Margin	n/a

Dividends & Yields

Theragen Etex Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.36%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	27.91%
FCF Yield	-3.87%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Theragen Etex Co.,Ltd. has an Altman Z-Score of 1.94. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.94
Piotroski F-Score	n/a